Top Stories
Latest Coverage
Why Have Bispecific Antibodies Become a Global Hotspot in Cancer Drug Development?
In recent years, bispecific antibodies (BsAbs) have rapidly emerged as one of the most closely watched innovations in...
In recent years, bispecific antibodies (BsAbs) have rapidly emerged as one of the most closely watched innovations in...
The First AI-Designed Drugs Enter Clinical Trials: A Historic Breakthrough for the Pharmaceutical Industry
In recent years, Artificial Intelligence (AI) has been transforming the global healthcare industry at an unprecedente...
In recent years, Artificial Intelligence (AI) has been transforming the global healthcare industry at an unprecedente...
NaPi2b Emerges as a New Ovarian Cancer Target: Two ADC Therapies Report Encouraging Clinical Data
At the 2026 ASCO Annual Meeting, new developments once again drew attention in the ovarian cancer ADC field.
At the 2026 ASCO Annual Meeting, new developments once again drew attention in the ovarian cancer ADC field.
How Can a Box of Medicine Travel Thousands of Miles? The Power Behind Pharmaceutical Logistics Coverage
When a patient receives a box of medicine from a hospital pharmacy, they rarely realize that the medication may have ...
When a patient receives a box of medicine from a hospital pharmacy, they rarely realize that the medication may have ...
Why Do Patients Often Have More Treatment Options After a Drug Patent Expires?
In the healthcare field, people frequently hear terms such as “drug patent expiration,” “domestic alternatives,” “gen...
In the healthcare field, people frequently hear terms such as “drug patent expiration,” “domestic alternatives,” “gen...
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
Oral Weight-Loss Drug Welcomes a New Competitor: AI-Designed Drug MDR-001 Enters Phase III Clinical Trials
